Hospital News and Research

RSS

Two DIFICID Phase 3 trial data in C. difficile presented at DDW conference

Optimer Pharmaceuticals, Inc. today announced the presentation of two abstracts at the 2011 Digestive Disease Week conference highlighting additional analyses of data from Phase 3 trials of DIFICID, an investigational product for the treatment of Clostridium difficile infection.

11 May 2011

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

UCB announced today results from a post hoc analysis of the RAPID 1 study published in the Journal of Rheumatology. The results suggest moderate to severe rheumatoid arthritis patients treated with Cimzia, the only approved PEGylated anti-TNF, together with methotrexate, achieved a rapid response associated with improved long-term outcomes one year after treatment began.

11 May 2011

USA Today: Uninsured hospitalizations result in a hefty unpaid tab

Uninsured Americans — including those with incomes well above the poverty line — leave hospitals with unpaid tabs of up to $49 billion a year, according to a government study released today. On average, uninsured families pay only about 12 percent of their hospital bills in full.

11 May 2011

Adherence to disease-modifying drugs is low in patients with multiple sclerosis

Disease-modifying drugs (DMDs) are injected medications used to slow the progression of multiple sclerosis, and have been shown to reduce the frequency and severity of relapses. But according to a new study led by St. Michael's Hospital and the Institute for Clinical Evaluative Sciences, adherence to all DMDs is low, with less than half of patients, or 44 per cent, continually adherent after two years.

11 May 2011

Reducing hearing aid cost does not improve device purchase

Lowering the cost of hearing aids isn't enough to motivate adults with mild hearing loss to purchase a device at a younger age or before their hearing worsens, according to researchers at Henry Ford Hospital.

11 May 2011

Study stresses importance of rapid intervention to prevent Self-Embedding Behavior in adolescents

While the disturbing act of self-injury is nothing new to adolescents, researchers and physicians at Nationwide Children's Hospital have identified a more severe type of behavior that is raising some concern among medical professionals.

11 May 2011

BioAlliance Pharma enters license deal with Sosei to commercialize Loramyc in Japan

BioAlliance Pharma, a company dedicated to specialty and orphan pharma products in oncology and supportive care, today announced that it has entered into an exclusive licensing agreement with Sosei Co. Ltd. for commercialization rights in Japan for Loramyc muco-adhesive buccal tablet.

11 May 2011

Scientists to develop 'eTraining' system for doctors and healthcare providers

Many people use fitness studios to get back into shape after an injury. Fraunhofer researchers are now developing a system that will provide doctors with data on the exercises people do on the various machines. This should help them plan better training programs.

11 May 2011

Two DIFICID Phase 3 study data in C. difficile presented at ECCMID conference

Optimer Pharmaceuticals, Inc. today announced the presentation of two abstracts at the 21st European Congress of Clinical Microbiology and Infectious Diseases conference in Milan, Italy highlighting additional analyses of the Phase 3 data of DIFICID for the treatment of Clostridium difficile infection.

11 May 2011

Sosei acquires rights to Loramyc in Japan from BioAlliance Pharma

Sosei Group Corporation, the biopharmaceutical company, today announces that Sosei Co., Ltd., its wholly owned Japanese subsidiary, acquired development and commercialization rights to Loramyc (miconazole Lauriad) in Japan from BioAlliance Pharma.

11 May 2011

Press Ganey creates comprehensive new tool for hospitalists

Approximately half of all hospitals in the U.S. employ hospitalists, and according to the Society of Hospital Medicine, the number of hospitalists increased by 10,000 from 2007 to 2010.

11 May 2011

Novel two-drug combination cures young patient with extensively drug-resistant tuberculosis

Belgian physicians report they have cured a young patient with extensively drug-resistant tuberculosis (XDR-TB) using a novel two-drug combination developed by researchers at Albert Einstein College of Medicine of Yeshiva University. The report, published in the Pediatric Infectious Disease Journal, marks the first known clinical use of this treatment for XDR-TB, the most deadly form of the disease.

11 May 2011

Scleroderma is an independent determinant for coronary calcification, study suggests

A new study by researchers in Hong Kong suggests that systemic sclerosis is an independent determinant for moderate to severe coronary calcification or atherosclerosis.

11 May 2011

Zebrafish research identifies undiscovered high-risk genetic features in T-cell acute lymphocytic leukemia

Leukemia is the most common childhood cancer; it also occurs in adults. Now researchers working with zebrafish at Huntsman Cancer Institute (HCI) at the University of Utah have identified previously undiscovered high-risk genetic features in T-cell acute lymphocytic leukemia (T-ALL), according to an article published online May 9, 2011, in the cancer research journal Oncogene.

11 May 2011

Washington Post examines Iraq's Baghdad Hospital

In an article looking at Baghdad Hospital, the Washington Post reports that "[i]t is difficult to overstate how far [the hospital] has come since the worst days of the war, when supplies were so scarce that doctors sometimes performed open heart surgery without gloves. ... Arriving at work was a small miracle: The hospital has lost at least 40 doctors to assassins since 2004 - they are still occasionally targeted - and their photos stare down from walls."

11 May 2011

$Study: Only 15% of heart failure patients with spinal fractures are being treated for osteoporosis$

Study: Only 15% of heart failure patients with spinal fractures are being treated for osteoporosis

One in 10 heart failure patients had compression fractures in the spine that could have been detected by a chest X-ray, but few are receiving treatment to help prevent such fractures according to a Canadian study published in the American Heart Association journal Circulation: Heart Failure.

11 May 2011

Second subject enrolled in human embryonic stem cell therapy trial for subacute thoracic spinal cord injury

Researchers at Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine and The Rehabilitation Institute of Chicago (RIC) recently enrolled their first subject in a national clinical research trial of a human embryonic stem cell-based therapy for participants with a subacute thoracic spinal cord injury.

11 May 2011

Chicago Magazine selects three Gottlieb physicians as region's 'medical MVPs'

Three Gottlieb Memorial Hospital physicians have been selected as the region's "medical MVPs" by Chicago Magazine in their "Best Sports Medicine Doctors in Chicago and the Suburbs."

11 May 2011

Tenet rejects Community Health's 'best and final' offer

Hospital operator Tenet Healthcare Corp. on Monday rejected Community Health Systems Inc.'s latest buyout offer, which had been increased by about 21 percent. Community's latest offer had been set to expire Monday and had said the latest proposal represented its final offer. Tenet says the offer still undervalues the company.

11 May 2011

16-year-old uses supercomputing network to invent new drug cocktail for cystic fibrosis

While many 16-year-olds are content with PlayStation, Toronto-area student Marshall Zhang used the Canadian SCINET supercomputing network to invent a new drug cocktail which could one day help treat cystic fibrosis.

11 May 2011

Hospital News and Research

Two DIFICID Phase 3 trial data in C. difficile presented at DDW conference

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

USA Today: Uninsured hospitalizations result in a hefty unpaid tab

Adherence to disease-modifying drugs is low in patients with multiple sclerosis

Reducing hearing aid cost does not improve device purchase

Study stresses importance of rapid intervention to prevent Self-Embedding Behavior in adolescents

BioAlliance Pharma enters license deal with Sosei to commercialize Loramyc in Japan

Scientists to develop 'eTraining' system for doctors and healthcare providers

Two DIFICID Phase 3 study data in C. difficile presented at ECCMID conference

Sosei acquires rights to Loramyc in Japan from BioAlliance Pharma

Press Ganey creates comprehensive new tool for hospitalists

Novel two-drug combination cures young patient with extensively drug-resistant tuberculosis

Scleroderma is an independent determinant for coronary calcification, study suggests

Zebrafish research identifies undiscovered high-risk genetic features in T-cell acute lymphocytic leukemia

Washington Post examines Iraq's Baghdad Hospital

Study: Only 15% of heart failure patients with spinal fractures are being treated for osteoporosis

Second subject enrolled in human embryonic stem cell therapy trial for subacute thoracic spinal cord injury

Chicago Magazine selects three Gottlieb physicians as region's 'medical MVPs'

Tenet rejects Community Health's 'best and final' offer

16-year-old uses supercomputing network to invent new drug cocktail for cystic fibrosis

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News